Lemaitre Vascular Inc. (LMAT) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lemaitre Vascular Inc. (LMAT:NASDAQ), powered by AI.

Current Price
$93.95
P/E Ratio
36.8
Market Cap
2.1B
Sector
Healthcare
What is the Lemaitre Vascular Inc. stock price forecast?

Lemaitre Vascular Inc. is currently trading at $93.95. View real-time AI analysis on Alpha Lenz.

What is Lemaitre Vascular Inc. insider trading activity?

View the latest insider trading data for Lemaitre Vascular Inc. on Alpha Lenz.

What is Lemaitre Vascular Inc.'s P/E ratio?

Lemaitre Vascular Inc.'s P/E ratio is 36.8.

Lemaitre Vascular Inc.

NASDAQ · LMAT
$93.95+1.74(+1.89%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Lemaitre Vascular Inc.'s future dividend policy...
Alpha Chat Insight

Lemaitre Vascular Inc. trades at a P/E of 36.8 (premium valuation) with strong ROE of 15.8%. 3Y revenue CAGR of 15.6% highlights clear growth momentum.

Ask for details

Company Overview

Lemaitre Vascular Inc. is a prominent medical device company specializing in the development and production of innovative surgical solutions for patients with peripheral vascular disease. As a key player in healthcare, the company's primary objective is to enhance the quality of life and improve outcomes for patients suffering from vascular ailments. Lemaitre Vascular’s comprehensive product portfolio includes a range of grafts, stents, patches, and biologic solutions designed specifically for vascular surgery, endovenous interventions, and diagnostic procedures. The company's products serve a crucial role in the medical industry, particularly within the cardiovascular and peripheral vascular markets. By addressing complex surgical needs and offering specialized vascular solutions, Lemaitre Vascular supports healthcare professionals worldwide in delivering life-saving treatments. Its commitment to research, development, and innovation positions it as a significant contributor to the medical technology sector, ensuring continuous advancement in surgical techniques and patient care.

CEOMr. George W. LeMaitre
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees651

Company Statistics

FY 2025

Profile

$2.13BMarket Cap
$249.60MRevenue
0.00Shares Out
651Employees

Margins

71.53%Gross
31.13%EBITDA
27.21%Operating
30.12%Pre-Tax
23.13%Net

Valuation

36.84P/E
5.40P/B
8.52EV/Sales
29.40EV/EBITDA
28.56P/FCF

Growth (CAGR)

15.58%Rev 3Yr
14.05%Rev 5Yr
31.40%Op Inc 3Yr
19.12%Op Inc 5Yr
40.91%Net Inc 3Yr
22.16%Net Inc 5Yr

Returns

9.89%ROA
15.80%ROE
13.77%ROIC

Financial Health

$28.24MCash & Cash Equivalents
$193.93MNet Debt
56.46%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Lemaitre Vascular Inc. (ticker: LMAT) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 651 employees. Market cap is $2.1B.

The current price is $93.95 with a P/E ratio of 36.84x and P/B of 5.4x.

ROE is 15.80% and operating margin is 27.21%. Annual revenue is $250M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Lemaitre Vascular Inc. (LMAT) Stock Forecast 2026 $93.95 — Price, Financials & Analyst Targets | Alpha Lenz